Developer docs
API playgroundTry for free, no card

Search company profiles

Cannabix Technologies

Full company profile

uuid0004jv6

Namestring
Cannabix Technologies
Legal namestring
Cannabix Technologies Inc.
Company typeenum
Public
Founded yearint
2014
Descriptiontext

Cannabix Technologies Inc. is a Canadian micro-cap public company (CSE: BLO; OTC: BLOZF; FWB: 8CT), headquartered in Burnaby, British Columbia, that develops non-invasive breath testing technologies for the detection of recent cannabis (THC) and alcohol use. Its core technology combines a proprietary Breath Collection Unit (BCU) — which captures breath samples in the field — with laboratory confirmation via Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS), delivered in partnership with Omega Laboratories Inc. The system is positioned around a roughly four-hour detection window that aligns with impairment rather than historical exposure, addressing limitations of urine-based testing. Supporting technologies include FAIMS-based field screening (Field Asymmetric Ion Mobility Spectrometry), a THC Breath Analyzer (THCBA) point-of-care device developed through version 4.0, and a contactless Contactless Alcohol Breathalyzer (CAB) for workplace and in-vehicle deployment.

The company's commercial product portfolio centers on the Marijuana Breath Test (MBT) system (BCU plus proprietary Breath Cartridges) for law enforcement and workplace safety buyers, and the BreathLogix automated alcohol screening platform sold primarily through exclusive distribution partners in Australia (Breathalyser Sales & Service Pty Ltd) and Quebec (Alco Prevention Canada), with direct enterprise field sales in the rest of North America. Pricing is quote-based with multi-year contract cadence; no standard pricing is published. Revenue mechanics blend one-time hardware sales, recurring consumables (breath cartridges), and partner-delivered laboratory analysis services. The primary customer segments are law enforcement and government agencies (police departments, district attorneys' offices, criminalistics laboratories) and workplace safety buyers in mining, construction, municipal services, aviation, oil and gas, and heavy materials — with clinical validation partners providing research support. Cannabix holds granted US and Canadian patents on its cannabis detection devices and FAIMS technology, has filed PCT applications for breath capture and contactless analysis, and in May 2026 secured UL and CSA electrical safety certifications for the BCU, enabling formal government and enterprise procurement participation.

Short descriptiontext

Cannabix Technologies (CSE: BLO) develops non-invasive breath testing devices that detect recent cannabis (THC) and alcohol use, combining a proprietary Breath Collection Unit with LC-MS/MS laboratory confirmation. It sells the Marijuana Breath Test system to law enforcement and the BreathLogix alcohol platform to workplace safety buyers across North America and Australia.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersBurnaby, Canada
HQ citystring
Burnaby
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
breath analysis technology, THC detection devices, alcohol screening systems, workplace drug testing, law enforcement breathalyzers
Industry2 codes
PRIMARYIMAGAFAC
Test & Measurement Equipment (Oscilloscopes, DAQ, signal analyzers, calibration benches)
Industrials, Manufacturing & Construction/Electrical Equipment & Industrial Electronics/Sensors, Instrumentation & Measurement (Industrial sensing, metrology, test)
SECONDARYHLAGADAA
Bioanalytical Testing (PK/ADA/NAb)
NAICS code2 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Testing Laboratories and Services541380
SIC code2 codes
  • Laboratory Analytical Instruments3826
  • Services-Testing Laboratories8734
Product category
Breath Analysis and Drug Testing Devices
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model3 records
1Breath Collection Unit (BCU) Hardware Sales
TypeHardware Sales
Description

Sale of the proprietary Breath Collection Unit (BCU) hardware device to law enforcement agencies, workplaces, and government entities. This is a one-time capital equipment sale model. Units are deployed in the field and used to collect breath samples for transport to partner laboratories for analysis.

globenewswire.com
2BreathLogix Device and Consumables
TypeHardware Sales
Description

Sale of BreathLogix branded devices (via exclusive Australian distribution partner Breathalyser Sales & Service) and associated consumables (breath collection cartridges/media). The consumables represent a recurring consumables revenue stream tied to the volume of tests conducted.

stocktitan.net
3Laboratory Analysis Services (via Omega Partnership)
TypeManaged Services
Description

Laboratory confirmation services using LC-MS/MS, conducted by partner Omega Laboratories Inc. Revenue from these services flows through the strategic partnership as part of the phased commercialization model. Omega performs the analytical testing on breath samples collected by the BCU hardware.

prnewswire.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Pricing details1 tier
1Enterprise / government custom pricing — quote-based
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is negotiated on a per-customer basis. Government and law enforcement agencies, large workplace safety enterprises, and distribution partners receive custom quotes reflecting their specific deployment requirements, volume needs, and service scope.

globenewswire.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1BreathLogix
Description

Automated alcohol screening technology platform for workplace safety including contactless breath alcohol testing devices

cannabixtechnologies.com
+3 more records
Core offering1 text field

Cannabix Technologies develops and manufactures non-invasive breath testing hardware systems for detecting recent cannabis (THC) and alcohol use. Its core offerings are the Cannabix Marijuana Breath Test (MBT) — using the Breath Collection Unit (BCU) and proprietary cartridges coupled with LC-MS laboratory confirmation — and the BreathLogix automated, contactless alcohol breathalyzer with its BreathLogixConnect data management platform. The products are sold to law enforcement agencies, government bodies, and employers in safety-sensitive industries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • ~4-hour detection window correlates with impairment rather than historical use (vs. 30+ days for urine-based THC testing)
+4 more records
Product overview1 text field

Cannabix Technologies offers a portfolio of breath testing products for detecting THC (marijuana) and alcohol. The core offerings include the Cannabix Marijuana Breath Test (MBT) system consisting of the Breath Collection Unit and Breath Cartridges for delta-9 THC detection, and the BreathLogix alcohol screening platform with wall-mounted contactless devices. Supporting products include the BreathLogixConnect data management platform, THC Breath Analyzer (THCBA) for point-of-care screening, and laboratory equipment including the MS Breath Sampler (MSBS) for mass spectrometry confirmation. The company also developed FAIMS technology for portable THC detection and Contactless Alcohol Breathalyzer (CAB) devices for workplace and vehicle applications.

Product and service9 records
1Cannabix Marijuana Breath Test (MBT)
CategoryDrug Testing Device
Description

Non-invasive breath testing system that detects delta-9 THC in breath within approximately 2-4 hours of cannabis consumption, designed for workplace safety and law enforcement applications. Uses the proprietary Breath Collection Unit (BCU) and Breath Cartridges with LC-MS/MS laboratory confirmation.

2BreathLogix Alcohol Breathalyzer
CategoryAlcohol Screening Device
Description

Fully automated, contactless breath alcohol screening system for workplace settings. Provides rapid, unmanned alcohol testing with photo capture, real-time alerts, and integration with the BreathLogixConnect data management platform. Approved by the U.S. National Highway Traffic Safety Administration.

3BreathLogixConnect
CategoryData Management Platform
Description

Cloud-based data management platform for BreathLogix devices that provides testing data access, reports, graphs, summaries, and automated alert notifications, leveraging AWS infrastructure for security and identity management.

4Breath Collection Unit (BCU)
CategorySample Collection Device
Description

Portable handheld device that collects breath samples for laboratory analysis. Core hardware component of the MBT system that captures exhaled breath for delta-9 THC detection, certified to UL 61010-1 and CSA 61010-1-12 standards.

5THC Breath Analyzer (THCBA)
CategoryPoint-of-Care Drug Testing Device
Description

Drug screening device designed for point-of-care detection of delta-9 THC in breath, providing results in under five minutes. Multiple versions developed with machine learning database training for improved sensitivity ranges.

6Contactless Alcohol Breathalyzer (CAB)
CategoryContactless Alcohol Detection Device
Description

Wall-mounted and in-vehicle breath alcohol detection device that operates in contactless mode without mouthpieces or straws. Designed for workplace pre-access testing and vehicle integration, featuring photo identity confirmation and real-time BAC results.

7MS Breath Sampler (MSBS)
CategoryLaboratory Equipment
Description

Laboratory-based mass spectrometer front-end hardware that analyzes breath samples collected by the BCU. Utilizes liquid secondary adsorption technique for efficient THC detection with results in under 2 minutes without sample preparation.

8Breath Cartridges
CategoryConsumable Accessories
Description

Proprietary single-use breath collection cartridges used with the Breath Collection Unit to capture and preserve breath samples for LC-MS laboratory analysis, representing a recurring consumables revenue stream.

9FAIMS Detection Unit
CategoryResearch and Detection Technology
Description

Field asymmetric waveform ion mobility spectrometry technology for detection of non-volatile compounds like THC in breath. Uses ion mobility filtering techniques related to mass spectrometry for portable drug detection.

Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Omega Laboratories Inc. is the primary strategic and co-development partner for Cannabix's Marijuana Breath Tester (MBT) system. The partnership operates on a phased commercialization model spanning more than 20 months of collaboration. Under the agreement, Cannabix supplies the Breath Collection Unit (BCU) hardware and Omega Laboratories provides LC-MS/MS laboratory confirmation analysis services. Together, the two companies form an end-to-end solution for court-admissible cannabis breath testing. The partnership also involves regulatory engagement with Health Canada as part of the commercialization pathway.

2Breathalyser Sales & Service Pty Ltd
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Breathalyser Sales & Service Pty Ltd is the exclusive distribution partner for the BreathLogix system in Australia. The partner covers all aspects of sales, distribution, service, and customer support for mining, municipal, and aviation workplace safety customers across Australia. This exclusive arrangement provides Cannabix with immediate market access to the Australian workplace safety sector without requiring direct local entity establishment.

stocktitan.net
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Alco Prevention Canada serves as a regional distributor for Cannabix's products in the province of Quebec. Alco Prevention Canada handles local sales, deployment, and customer support for the Quebec market, complementing Cannabix's direct sales operations in the rest of Canada.

4North Louisiana Criminalistics Laboratory
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

North Louisiana Criminalistics Laboratory served as a testing and validation host for the MBT system. The laboratory provided the controlled environment necessary to process and analyze breath samples collected during the technology development and validation phase.

cannabixtechnologies.com
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

Friedel Clinic, a Montana-based medical and clinical research organization, conducted clinical testing and data collection for the MBT / THC breath analysis technology as part of the research validation process. The clinic provided access to human subjects and clinical expertise for the validation studies.

6Montgomery County Police Department
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

The Montgomery County Police Department participated in field testing and validation of the MBT system in a real-world law enforcement setting. The agency's involvement provided practical feedback on field deployment usability and generated real-world validation data.

cannabixtechnologies.com
Strategic tierMinorTypeImplementation/ SI/ Consulting Partner
Description

The Warren County, PA District Attorney's Office participated in a pilot program for the MBT system, evaluating its suitability as evidence in cannabis-related prosecutions. The pilot provided feedback on court-admissibility and operational integration with prosecutorial workflows.

8Audacia Bioscience
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Audacia Bioscience, led by Dr. Phillip Olla, conducted independent research and THC breath analysis validation studies for Cannabix Technologies. The independent scientific validation by Audacia strengthens the credibility of the technology's detection accuracy and supports regulatory and legal acceptance of the system.

cannabixtechnologies.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Developer of the HOUND MARIJUANA BREATHALYZER, the most direct competitor to Cannabix's MBT system. Both companies target the same breath-based THC detection opportunity for law enforcement and workplace safety, with Hound Labs having achieved earlier commercialization and law enforcement partnerships.

TypeDirect peer
Description

US-based manufacturer of professional breath alcohol testing devices (LifeLoc FC Series) for law enforcement, workplace, and corrections markets. Comparable in the breath-based testing device category and customer base, though Lifeloc currently focuses on alcohol rather than THC detection.

TypeDirect peer
Description

Manufacturer of evidential breath alcohol testing instruments (Intoxilyzer) widely used by US law enforcement. Comparable as a breath-testing device maker serving law enforcement, with deep customer relationships in the impairment testing market that Cannabix also targets.

TypeDirect peer
Description

Manufacturer of intoxilyzer breath alcohol testing equipment for law enforcement and corrections. Comparable as a specialized breath-testing device vendor with overlapping law enforcement and workplace safety customers, though Cannabix's focus on cannabis detection differentiates the technology offering.

5Dräger
TypeBroad incumbent
Description

German industrial safety and medical technology company with a broad breath alcohol and drug detection product portfolio (Dräger Alcotest). Comparable in workplace and law enforcement breath testing but does not currently offer a commercial breath-based THC detection system at Cannabix's level of specificity.

TypeBroad incumbent
Description

Global leader in analytical instruments, including the mass spectrometry and LC-MS/MS systems used by partner Omega Laboratories for THC confirmation. Comparable as a provider of the underlying laboratory analytical instrument technology central to Cannabix's MBT confirmation workflow.

TypeBroad incumbent
Description

Major clinical laboratory services company providing workplace drug testing, including urine-based cannabis screening. Comparable as a participant in the workplace drug testing market that Cannabix targets, though Quest's primary modality (urine) lacks the recent-use detection window of Cannabix's breath-based approach.

TypeBroad incumbent
Description

Major manufacturer of analytical laboratory instruments including mass spectrometers and chromatography systems. Comparable as a provider of analytical measurement technology used in laboratory-based confirmation of substances, an essential element of Cannabix's MBT solution.

9SCIEX
TypeBroad incumbent
Description

Specialized provider of mass spectrometry and LC-MS/MS instruments widely used in forensic and clinical laboratories. Comparable in providing the laboratory analytical instrumentation that underpins the confirmation workflow for cannabis and other substance testing.

TypeOthers
Description

Cannabix's flagship strategic partner and an international leader in forensic drugs of abuse testing for over 25 years. Bill Corl, CEO of Omega Laboratories, also sits on Cannabix's board. Comparable as a laboratory services provider in the cannabis testing space, though operating as a partner rather than a competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles8 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Cannabix Technologies

Breath Analysis and Drug Testing Devicescannabixtechnologies.com

Cannabix Technologies (CSE: BLO) develops non-invasive breath testing devices that detect recent cannabis (THC) and alcohol use, combining a proprietary Breath Collection Unit with LC-MS/MS laboratory confirmation. It sells the Marijuana Breath Test system to law enforcement and the BreathLogix alcohol platform to workplace safety buyers across North America and Australia.

What Cannabix Technologies does

Cannabix Technologies Inc. is a Canadian micro-cap public company (CSE: BLO; OTC: BLOZF; FWB: 8CT), headquartered in Burnaby, British Columbia, that develops non-invasive breath testing technologies for the detection of recent cannabis (THC) and alcohol use. Its core technology combines a proprietary Breath Collection Unit (BCU) — which captures breath samples in the field — with laboratory confirmation via Liquid Chromatography–Tandem Mass Spectrometry (LC-MS/MS), delivered in partnership with Omega Laboratories Inc. The system is positioned around a roughly four-hour detection window that aligns with impairment rather than historical exposure, addressing limitations of urine-based testing. Supporting technologies include FAIMS-based field screening (Field Asymmetric Ion Mobility Spectrometry), a THC Breath Analyzer (THCBA) point-of-care device developed through version 4.0, and a contactless Contactless Alcohol Breathalyzer (CAB) for workplace and in-vehicle deployment.

The company's commercial product portfolio centers on the Marijuana Breath Test (MBT) system (BCU plus proprietary Breath Cartridges) for law enforcement and workplace safety buyers, and the BreathLogix automated alcohol screening platform sold primarily through exclusive distribution partners in Australia (Breathalyser Sales & Service Pty Ltd) and Quebec (Alco Prevention Canada), with direct enterprise field sales in the rest of North America. Pricing is quote-based with multi-year contract cadence; no standard pricing is published. Revenue mechanics blend one-time hardware sales, recurring consumables (breath cartridges), and partner-delivered laboratory analysis services. The primary customer segments are law enforcement and government agencies (police departments, district attorneys' offices, criminalistics laboratories) and workplace safety buyers in mining, construction, municipal services, aviation, oil and gas, and heavy materials — with clinical validation partners providing research support. Cannabix holds granted US and Canadian patents on its cannabis detection devices and FAIMS technology, has filed PCT applications for breath capture and contactless analysis, and in May 2026 secured UL and CSA electrical safety certifications for the BCU, enabling formal government and enterprise procurement participation.

Cannabix Technologies firmographics

Firmographics
Name
Cannabix Technologies
Legal name
Cannabix Technologies Inc.
Website
https://cannabixtechnologies.com
Company type
Public
Founded year
2014
Operating status
Operating
Headcount range
1–10 employees
Short description
Cannabix Technologies (CSE: BLO) develops non-invasive breath testing devices that detect recent cannabis (THC) and alcohol use, combining a proprietary Breath Collection Unit with LC-MS/MS laboratory confirmation. It sells the Marijuana Breath Test system to law enforcement and the BreathLogix alcohol platform to workplace safety buyers across North America and Australia.
Ownership category
akta.pro rank

Cannabix Technologies industry classification

Industry
Product category
Breath Analysis and Drug Testing Devices
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Testing Laboratories and Services (541380)
SIC
Laboratory Analytical Instruments (3826), Services-Testing Laboratories (8734)
akta.pro industry
PRIMARYIMAGAFAC
Test & Measurement Equipment (Oscilloscopes, DAQ, signal analyzers, calibration benches)
Industrials, Manufacturing & Construction/Electrical Equipment & Industrial Electronics/Sensors, Instrumentation & Measurement (Industrial sensing, metrology, test)
SECONDARYHLAGADAA
Bioanalytical Testing (PK/ADA/NAb)

Keywords

  • Breath analysis technology
  • THC detection devices
  • Alcohol screening systems
  • Workplace drug testing
  • Law enforcement breathalyzers

Where Cannabix Technologies is headquartered

Location

Headquarters

HQ city
Burnaby
HQ country
Canada
HQ region
North America

Offices2 records

Markets served

Cannabix Technologies business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

  1. Breath Collection Unit (BCU) Hardware Sales: Sale of the proprietary Breath Collection Unit (BCU) hardware device to law enforcement agencies, workplaces, and government entities. This is a one-time capital equipment sale model. Units are deployed in the field and used to collect breath samples for transport to partner laboratories for analysis.
  2. BreathLogix Device and Consumables: Sale of BreathLogix branded devices (via exclusive Australian distribution partner Breathalyser Sales & Service) and associated consumables (breath collection cartridges/media). The consumables represent a recurring consumables revenue stream tied to the volume of tests conducted.
  3. Laboratory Analysis Services (via Omega Partnership): Laboratory confirmation services using LC-MS/MS, conducted by partner Omega Laboratories Inc. Revenue from these services flows through the strategic partnership as part of the phased commercialization model. Omega performs the analytical testing on breath samples collected by the BCU hardware.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractEnterprise / government custom pricing — quote-based

Go-to-market motion3 records

Distribution channels3 records

Marketing channels4 records

Cannabix Technologies product offering

Product offering

Core offering

Cannabix Technologies develops and manufactures non-invasive breath testing hardware systems for detecting recent cannabis (THC) and alcohol use. Its core offerings are the Cannabix Marijuana Breath Test (MBT) — using the Breath Collection Unit (BCU) and proprietary cartridges coupled with LC-MS laboratory confirmation — and the BreathLogix automated, contactless alcohol breathalyzer with its BreathLogixConnect data management platform. The products are sold to law enforcement agencies, government bodies, and employers in safety-sensitive industries.

Product overview

Cannabix Technologies offers a portfolio of breath testing products for detecting THC (marijuana) and alcohol. The core offerings include the Cannabix Marijuana Breath Test (MBT) system consisting of the Breath Collection Unit and Breath Cartridges for delta-9 THC detection, and the BreathLogix alcohol screening platform with wall-mounted contactless devices. Supporting products include the BreathLogixConnect data management platform, THC Breath Analyzer (THCBA) for point-of-care screening, and laboratory equipment including the MS Breath Sampler (MSBS) for mass spectrometry confirmation. The company also developed FAIMS technology for portable THC detection and Contactless Alcohol Breathalyzer (CAB) devices for workplace and vehicle applications.

Differentiator

Problem solved

Functional benefit

Brands

  • BreathLogix: Automated alcohol screening technology platform for workplace safety including contactless breath alcohol testing devices
  • BreathLogixConnect
  • Marijuana Breath Test (MBT)
  • Breath Collection Unit (BCU)

Products and services

  • Cannabix Marijuana Breath Test (MBT) Non-invasive breath testing system that detects delta-9 THC in breath within approximately 2-4 hours of cannabis consumption, designed for workplace safety and law enforcement applications. Uses the proprietary Breath Collection Unit (BCU) and Breath Cartridges with LC-MS/MS laboratory confirmation.
  • BreathLogix Alcohol Breathalyzer Fully automated, contactless breath alcohol screening system for workplace settings. Provides rapid, unmanned alcohol testing with photo capture, real-time alerts, and integration with the BreathLogixConnect data management platform. Approved by the U.S. National Highway Traffic Safety Administration.
  • BreathLogixConnect Cloud-based data management platform for BreathLogix devices that provides testing data access, reports, graphs, summaries, and automated alert notifications, leveraging AWS infrastructure for security and identity management.
  • Breath Collection Unit (BCU) Portable handheld device that collects breath samples for laboratory analysis. Core hardware component of the MBT system that captures exhaled breath for delta-9 THC detection, certified to UL 61010-1 and CSA 61010-1-12 standards.
  • THC Breath Analyzer (THCBA) Drug screening device designed for point-of-care detection of delta-9 THC in breath, providing results in under five minutes. Multiple versions developed with machine learning database training for improved sensitivity ranges.
  • Contactless Alcohol Breathalyzer (CAB) Wall-mounted and in-vehicle breath alcohol detection device that operates in contactless mode without mouthpieces or straws. Designed for workplace pre-access testing and vehicle integration, featuring photo identity confirmation and real-time BAC results.
  • MS Breath Sampler (MSBS) Laboratory-based mass spectrometer front-end hardware that analyzes breath samples collected by the BCU. Utilizes liquid secondary adsorption technique for efficient THC detection with results in under 2 minutes without sample preparation.
  • Breath Cartridges Proprietary single-use breath collection cartridges used with the Breath Collection Unit to capture and preserve breath samples for LC-MS laboratory analysis, representing a recurring consumables revenue stream.
  • FAIMS Detection Unit Field asymmetric waveform ion mobility spectrometry technology for detection of non-volatile compounds like THC in breath. Uses ion mobility filtering techniques related to mass spectrometry for portable drug detection.

Quantifiable outcome

  • ~4-hour detection window correlates with impairment rather than historical use (vs. 30+ days for urine-based THC testing)
  • +4 more outcomes

Companies that use Cannabix Technologies

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Cannabix Technologies technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature5 records

Cannabix Technologies partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered flagship, core and minor.

  • Omega Laboratories Inc.flagshipStrategic or Co-development PartnerOmega Laboratories Inc. is the primary strategic and co-development partner for Cannabix's Marijuana Breath Tester (MBT) system. The partnership operates on a phased commercialization model spanning more than 20 months of collaboration. Under the agreement, Cannabix supplies the Breath Collection Unit (BCU) hardware and Omega Laboratories provides LC-MS/MS laboratory confirmation analysis services. Together, the two companies form an end-to-end solution for court-admissible cannabis breath testing. The partnership also involves regulatory engagement with Health Canada as part of the commercialization pathway.
  • Breathalyser Sales & Service Pty LtdcoreChannel Partner/ Reseller/ DistributorBreathalyser Sales & Service Pty Ltd is the exclusive distribution partner for the BreathLogix system in Australia. The partner covers all aspects of sales, distribution, service, and customer support for mining, municipal, and aviation workplace safety customers across Australia. This exclusive arrangement provides Cannabix with immediate market access to the Australian workplace safety sector without requiring direct local entity establishment.
  • Alco Prevention CanadacoreChannel Partner/ Reseller/ DistributorAlco Prevention Canada serves as a regional distributor for Cannabix's products in the province of Quebec. Alco Prevention Canada handles local sales, deployment, and customer support for the Quebec market, complementing Cannabix's direct sales operations in the rest of Canada.
  • North Louisiana Criminalistics LaboratoryminorImplementation/ SI/ Consulting PartnerNorth Louisiana Criminalistics Laboratory served as a testing and validation host for the MBT system. The laboratory provided the controlled environment necessary to process and analyze breath samples collected during the technology development and validation phase.
  • Friedel ClinicminorImplementation/ SI/ Consulting PartnerFriedel Clinic, a Montana-based medical and clinical research organization, conducted clinical testing and data collection for the MBT / THC breath analysis technology as part of the research validation process. The clinic provided access to human subjects and clinical expertise for the validation studies.
  • Montgomery County Police DepartmentminorImplementation/ SI/ Consulting PartnerThe Montgomery County Police Department participated in field testing and validation of the MBT system in a real-world law enforcement setting. The agency's involvement provided practical feedback on field deployment usability and generated real-world validation data.
  • Warren County, Pennsylvania District Attorney's OfficeminorImplementation/ SI/ Consulting PartnerThe Warren County, PA District Attorney's Office participated in a pilot program for the MBT system, evaluating its suitability as evidence in cannabis-related prosecutions. The pilot provided feedback on court-admissibility and operational integration with prosecutorial workflows.
  • Audacia BioscienceminorStrategic or Co-development PartnerAudacia Bioscience, led by Dr. Phillip Olla, conducted independent research and THC breath analysis validation studies for Cannabix Technologies. The independent scientific validation by Audacia strengthens the credibility of the technology's detection accuracy and supports regulatory and legal acceptance of the system.

Scale indicators3 records

Recent moves6 records

Expansion highlights6 records

Cannabix Technologies competitors and assessment

Company assessment

Direct peers

  • Hound Labs: Developer of the HOUND MARIJUANA BREATHALYZER, the most direct competitor to Cannabix's MBT system. Both companies target the same breath-based THC detection opportunity for law enforcement and workplace safety, with Hound Labs having achieved earlier commercialization and law enforcement partnerships.
  • Lifeloc Technologies: US-based manufacturer of professional breath alcohol testing devices (LifeLoc FC Series) for law enforcement, workplace, and corrections markets. Comparable in the breath-based testing device category and customer base, though Lifeloc currently focuses on alcohol rather than THC detection.
  • Intoximeters: Manufacturer of evidential breath alcohol testing instruments (Intoxilyzer) widely used by US law enforcement. Comparable as a breath-testing device maker serving law enforcement, with deep customer relationships in the impairment testing market that Cannabix also targets.
  • CMI Inc. Manufacturer of intoxilyzer breath alcohol testing equipment for law enforcement and corrections. Comparable as a specialized breath-testing device vendor with overlapping law enforcement and workplace safety customers, though Cannabix's focus on cannabis detection differentiates the technology offering.

Broad incumbents

  • Dräger: German industrial safety and medical technology company with a broad breath alcohol and drug detection product portfolio (Dräger Alcotest). Comparable in workplace and law enforcement breath testing but does not currently offer a commercial breath-based THC detection system at Cannabix's level of specificity.
  • Thermo Fisher Scientific: Global leader in analytical instruments, including the mass spectrometry and LC-MS/MS systems used by partner Omega Laboratories for THC confirmation. Comparable as a provider of the underlying laboratory analytical instrument technology central to Cannabix's MBT confirmation workflow.
  • Quest Diagnostics: Major clinical laboratory services company providing workplace drug testing, including urine-based cannabis screening. Comparable as a participant in the workplace drug testing market that Cannabix targets, though Quest's primary modality (urine) lacks the recent-use detection window of Cannabix's breath-based approach.
  • Agilent Technologies: Major manufacturer of analytical laboratory instruments including mass spectrometers and chromatography systems. Comparable as a provider of analytical measurement technology used in laboratory-based confirmation of substances, an essential element of Cannabix's MBT solution.
  • SCIEX: Specialized provider of mass spectrometry and LC-MS/MS instruments widely used in forensic and clinical laboratories. Comparable in providing the laboratory analytical instrumentation that underpins the confirmation workflow for cannabis and other substance testing.

Others

  • Omega Laboratories: Cannabix's flagship strategic partner and an international leader in forensic drugs of abuse testing for over 25 years. Bill Corl, CEO of Omega Laboratories, also sits on Cannabix's board. Comparable as a laboratory services provider in the cannabis testing space, though operating as a partner rather than a competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Cannabix Technologies social profiles

Digital presence

Cannabix Technologies compliance and trust

Trust signal

Compliance4 records

Cannabix Technologies financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Cannabix Technologies leadership team

Management profile

Number of profiles

Profiles8 records

Cannabix Technologies funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Cannabix Technologies M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cannabix Technologies

What does Cannabix Technologies do?

Cannabix Technologies develops and manufactures non-invasive breath testing hardware systems for detecting recent cannabis (THC) and alcohol use. Its core offerings are the Cannabix Marijuana Breath Test (MBT) — using the Breath Collection Unit (BCU) and proprietary cartridges coupled with LC-MS laboratory confirmation — and the BreathLogix automated, contactless alcohol breathalyzer with its BreathLogixConnect data management platform. The products are sold to law enforcement agencies, government bodies, and employers in safety-sensitive industries.

Is Cannabix Technologies a public or private company?

Cannabix Technologies is a public company. It is classified as public and is currently operating.

When was Cannabix Technologies founded?

Cannabix Technologies was founded in 2014. It employs 1 to 10 people.

Where is Cannabix Technologies based?

Cannabix Technologies is headquartered in Burnaby, Canada, in the North America region.

How does Cannabix Technologies make money?

Three revenue lines are on record. Breath Collection Unit (BCU) Hardware Sales are the primary driver. The others are breathLogix Device and Consumables and laboratory Analysis Services (via Omega Partnership).

Who are Cannabix Technologies's main competitors?

Direct peers on record are Hound Labs, Lifeloc Technologies, Intoximeters and CMI Inc.. Broad incumbents are Dräger, Thermo Fisher Scientific, Quest Diagnostics, Agilent Technologies and SCIEX. Omega Laboratories is listed as an others.

Does Cannabix Technologies have an API?

Yes. BreathLogix Connect platform has API access for data integration purposes. The API is subject to fair use limits including rate limits, record retrieval caps, and throttling mechanisms. Users can access and export data through the platform interface.

What industry is Cannabix Technologies in?

Cannabix Technologies's product category is Breath Analysis and Drug Testing Devices. Its primary akta.pro industry code is IMAGAFAC, Test & Measurement Equipment (Oscilloscopes, DAQ, signal analyzers, calibration benches), with a secondary code of HLAGADAA, Bioanalytical Testing (PK/ADA/NAb). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business & FinancialCannabix Technologies To Present Multi-Drug Breath Technology At BC Centre For Excellence On Substance Use DisordersCannabix Technologies will present its multi-drug breath test platform at the BC Centre for Excellence on Substance Use Disorders. The platform detects delta-9 THC, amphetamines, cocaine, and opioids like fentanyl. The company sees potential for standardized breath collection and future multi-analyte testing.TradingViewCannabix Technologies to Present Multi-Drug Breath Technology at BC Centre for Excellence on Substance Use DisordersCannabix Technologies will present its multi-drug breath testing technology at the BC Centre for Excellence conference in Vancouver on November 13. The presentation will cover detection of delta-9 THC, amphetamines, cocaine, and opioids including fentanyl. The company highlights the Breath Collection Unit platform's potential for future multi-analyte testing.TradingViewCannabix Technologies Inc. (BLO) Reports Detection of THC and Other Drugs in BreathCannabix Technologies reported its Multi-Drug Breath Test platform detected delta-9 THC, amphetamines, methamphetamines, cocaine, opioids, and fentanyl in breath. The findings suggest broader analyte detection, but no study details or validation data were provided.Business & FinancialCannabix Technologies Announces Detection Of Fentanyl In Human BreathCannabix Technologies announced detection of fentanyl in human breath samples collected via its Breath Collection Unit and Breath Cartridge, analyzed by Omega Laboratories using LC-MS. The findings mark a milestone in expanding the company's breath testing platform beyond THC to multi-drug detection, with applications in workplace safety and law enforcement.GlobeNewswireCannabix Technologies Announces Detection of Fentanyl in Human BreathCannabix Technologies announced detection of fentanyl in human breath samples collected via its Breath Collection Unit and analyzed by Omega Laboratories. The findings mark a milestone in expanding the company's breath testing platform beyond THC to multi-drug detection, with applications in workplace safety and law enforcement.Business & FinancialCannabix Technologies Evaluating Expansion Into Breath-Based Health And Biomarker Market With Proprietary BCU“VOC” PlatformCannabix Technologies is evaluating its BCU VOC platform for expansion into the breath-based health and biomarker market. The portable device uses industry-standard thermal desorption tubes and could serve as a neutral hardware vendor for research labs and CROs. The company may avoid lengthy clinical trial pathways by focusing on consumables and hardware sales.Financial PostCannabix Technologies Evaluating Expansion into Breath-Based Health and Biomarker Market with Proprietary BCU "VOC" PlatformCannabix Technologies is evaluating expansion into breath-based health and biomarker markets with its BCU VOC platform, a portable handheld device for standardized breath sample collection. The platform can serve as an ambient air collector and offers a hardware-only alternative for labs, potentially bypassing lengthy clinical trial pathways.YahooCannabix Technologies Evaluating Expansion into Breath-Based Health and Biomarker Market with Proprietary BCU “VOC” PlatformCannabix Technologies is evaluating its Breath Collection Unit (BCU) VOC platform for expansion into breath biomarker research and diagnostics. The portable device uses industry-standard thermal desorption tubes and aims to serve as a neutral hardware vendor for labs and CROs. The company may bypass lengthy clinical trial pathways by offering only collection hardware.Ticker ReportCannabix Technologies Inc. (OTCMKTS:BLOZF) Stock Short Interest Declines 97.8%Cannabix Technologies' short interest fell 97.8% to 160 shares as of October 15th, down from 7,305 on September 30th. The stock traded at $0.34 on Monday, with a market cap of $41.40 million and a P/E ratio of -16.85.Financial PostCannabix Technologies Delivers First Breath-Based DOT-Like Multi-Drug Testing Panel for Recent-Use DetectionCannabix Technologies delivered its first commercial breath-based multi-drug test panel, modeled after the U.S. DOT urine testing program, covering amphetamines, cocaine, THC, opiates, and PCP. The panel was validated by Omega Laboratories and targets a 15-minute-to-4-hour detection window for recent-use testing in workplace and safety-sensitive settings.